Narcolepsy Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Narcolepsy Market is Segmented By Diagnosis Type (Polysomnography, Multiple Sleep Latency Test, Hypocretin/Orexin Level Test), By Treatment Type (Stimulants, Wakefulness-Promoting Agents, Antidepressants, Sodium Oxybate, Others), By Scale of Operation, (Large-scale Manufacturing, Small-scale/Specialty Manufacturing), By Age Group (Pediatric, Adult, Geriatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) , By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

Narcolepsy Market Leaders

  • Jazz Pharmaceuticals plc
  • Takeda Pharmaceutical Company
  • Teva Pharmaceuticals USA, Inc.
  • Vanda Pharmaceuticals
  • Kyowa Kirin, Inc.
*Disclaimer: Major players are listed in no particular order.

Narcolepsy Market - Company List

  • Jazz Pharmaceuticals plc
  • Takeda Pharmaceutical Company
  • Teva Pharmaceuticals USA, Inc.
  • Vanda Pharmaceuticals
  • Kyowa Kirin, Inc.
  • Sage Therapeutics
  • Athira Pharma
  • Aptinyx
  • CogState Ltd.
  • AgeneBio
  • 1ST Biotherapeutics, Inc.
  • ACADIA Pharmaceuticals Inc.
  • BrainX Corporation
  • CuraSen Therapeutics, Inc.
  • Bioprojet
  • Arena Pharmaceuticals
  • Graymark Healthcare
  • Avadel
  • Suven Life Sciences Limited
  • Axsome Therapeutics, Inc.
  • Syngene
  • WACKER